The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 134-142

  Oblak, Alja ^a   Jerala, Roman ^a,b  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b EN FIST CENTRE OF EXCELLENCE   (Slovenia)

Author keywords

Innate immunity; Lipid A; Lipopolysaccharide; MD 2; Selectivity; TLR4

Indexed keywords

LIPID A; LIPOPOLYSACCHARIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR 4;

ANTIGEN RECOGNITION; ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; HYDROPHOBICITY; IMMUNE RESPONSE; MUTAGENESIS; NONHUMAN; PHOSPHORYLATION; RHODOBACTER SPHAEROIDES; SPECIES DIFFERENCE; STATIC ELECTRICITY; ANIMAL; BACTERIA; CHEMISTRY; HUMAN; IMMUNE EVASION; IMMUNOLOGY;

ANIMALS; BACTERIA; HUMANS; IMMUNE EVASION; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4;

EID: 84912047328     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.034     Document Type: Article

References (89)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Barochia A., Solomon S., Cui X., Natanson C., Eichacker P.Q. Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Expert Opin. Drug Metab. Toxicol. 2011, 7:479-494.
3. Coats S., Reife R., Bainbridge B., Pham T., Darveau R. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at Toll-like receptor 4 in human endothelial cells. Infect. Immun. 2003, 71:6799-6807.
4. Coats S.R., Do C.T., Karimi-Naser L.M., Braham P.H., Darveau R.P. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell. Microbiol. 2007, 9:1191-1202.
5. Conde-Álvarez R., Arce-Gorvel V., Iriarte M., Manček-Keber M., Barquero-Calvo E., Palacios-Chaves L., Chacón-Díaz C., et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog. 2012, 8:e1002675.
6. Cullen T.W., Giles D.K., Wolf L.N., Ecobichon C., Boneca I.G., Trent M.S. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog. 2011, 7:e1002454.
7. Darveau R., Pham T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., Howald W., et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 2004, 72:5041-5051.
8. De Soyza A., Ellis C.D., Khan C.M.A., Corris P.A., Demarco de Hormaeche R. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am. J. Respir. Crit. Care Med. 2004, 170:70-77.
9. Delude R.L., Savedra R., Zhao H., Thieringer R., Yamamoto S., Fenton M.J., Golenbock D.T. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9288-9292.
10. Ernst R.K., Yi E.C., Guo L., Lim K.B., Burns J.L., Hackett M., Miller S.I. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286:1561-1565.
11. Ernst R.K., Hajjar A.M., Tsai J.H., Moskowitz S.M., Wilson C.B., Miller S.I. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J. Endotoxin Res. 2003, 9:395-400.
12. Fekonja O., Benčina M., Jerala R. Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling. J. Biol. Chem. 2012, 287:30993-31002.
13. Fransen F., Heckenberg S.G.B., Hamstra H.J., Feller M., Boog C.J.P., van Putten J.P.M., van de Beek D., et al. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 2009, 5:e1000396.
14. Galanos C., Lüderitz O., Rietschel E.T., Westphal O., Brade H., Brade L., Freudenberg M., et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 1985, 148:1-5.
15. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 1991, 266:19490-19498.
16. Gruber A., Mancek M., Wagner H., Kirschning C.J., Jerala R. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J. Biol. Chem. 2004, 279:28475-28482.
17. Gunn J.S., Lim K.B., Krueger J., Kim K., Guo L., Hackett M., Miller S.I. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 1998, 27:1171-1182.
18. Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., Miller S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276:250-253.
19. Gutsmann T., Schromm A.B., Brandenburg K. The physicochemistry of endotoxins in relation to bioactivity. Int. J. Med. Microbiol. 2007, 297:341-352.
20. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 2002, 3:354-359.
21. Hajjar A.M., Harvey M.D., Shaffer S.A., Goodlett D.R., Sjöstedt A., Edebro H., Forsman M., et al. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 2006, 74:6730-6738.
22. Heine H., Müller-Loennies S., Brade L., Lindner B., Brade H. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur. J. Biochem. 2003, 270:440-450.
23. Hurley J.C., Opal S.M. Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependent. J. Innate Immun. 2013, 5:555-564.
24. Ingalls R.R., Rice P.A., Qureshi N., Takayama K., Lin J.S., Golenbock D.T. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 1995, 63:3125-3130.
25. Ittig S., Lindner B., Stenta M., Manfredi P., Zdorovenko E., Knirel Y.A., dal Peraro M., et al. The lipopolysaccharide from Capnocytophaga canimorsus reveals an unexpected role of the core-oligosaccharide in MD-2 binding. PLoS Pathog. 2012, 8:e1002667.
26. Jones J.D.G., Dangl J.L. The plant immune system. Nature 2006, 444:323-329.
27. Jones J.W., Cohen I.E., Tureĉek F., Goodlett D.R., Ernst R.K. Comprehensive structure characterization of lipid A extracted from Yersinia pestis for determination of its phosphorylation configuration. J. Am. Soc. Mass Spectrom. 2010, 21:785-799.
28. Kawahara K., Tsukano H., Watanabe H., Lindner B., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 2002, 70:4092-4098.
29. Kawai T., Takeuchi O., Fujita T., Inoue J., Mühlradt P.F., Sato S., Hoshino K., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
30. Keber M.M., Gradisar H., Jerala R. MD-2 and Der p 2 - a tale of two cousins or distant relatives?. J. Endotoxin Res. 2005, 11:186-192.
31. Kieffer T.L., Cowley S., Nano F.E., Elkins K.L. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 2003, 5:397-403.
32. Knirel Y.A., Anisimov A.P. Lipopolysaccharide of Yersinia pestis, the cause of plague: structure, genetics, biological properties. Acta Naturae. 2012, 4:46-58.
33. Knirel Y.A., Lindner B., Vinogradov E.V., Kocharova N.A., Senchenkova S.N., Shaikhutdinova R.Z., Dentovskaya S.V., et al. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 2005, 44:1731-1743.
34. Kosma P. Chlamydial lipopolysaccharide. Biochim. Biophys. Acta Mol. Basis Dis. 1999, 1455:387-402.
35. Kulshin V.A., Zähringer U., Lindner B., Frasch C.E., Tsai C.M., Dmitriev B.A., Rietschel E.T. Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J. Bacteriol. 1992, 174:1793-1800.
36. Lapaque N., Moriyon I., Moreno E., Gorvel J.-P. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 2005, 8:60-66.
37. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996, 86:973-983.
38. Lembo A., Pelletier M., Iyer R., Timko M., Dudda J.C., West T.E., Wilson C.B., et al. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J. Immunol. 2008, 180:7574-7581.
39. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 2000, 105:497-504.
40. Lohmann K.L., Vandenplas M., Barton M.H., Moore J.N. Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells. J. Endotoxin Res. 2003, 9:33-37.
41. Mancek-Keber M., Jerala R. Structural similarity between the hydrophobic fluorescent probe and lipid A as a ligand of MD-2. FASEB J. 2006, 20:1836-1842.
42. Matsuura M., Takahashi H., Watanabe H., Saito S., Kawahara K. Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages. Clin. Vaccine Immunol. 2010, 17:49-55.
43. Medzhitov R., Preston-Hurlburt P., Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
44. Meng J., Lien E., Golenbock D.T. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J. Biol. Chem. 2010, 285:8695-8702.
45. Meng J., Drolet J.R., Monks B.G., Golenbock D.T. MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA. J. Biol. Chem. 2010, 285:27935-27943.
46. Montminy S.W., Khan N., McGrath S., Walkowicz M.J., Sharp F., Conlon J.E., Fukase K., et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 2006, 7:1066-1073.
47. Moran A., Lindner B., Walsh E. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 1997, 179:6453-6463.
48. Mullarkey M., Rose J.R., Bristol J., Kawata T., Kimura A., Kobayashi S., Przetak M., et al. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 2003, 304:1093-1102.
49. Muroi M., Tanamoto K. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa. J. Biol. Chem. 2006, 281:5484-5491.
50. Nahori M.-A., Fournié-Amazouz E., Que-Gewirth N.S., Balloy V., Chignard M., Raetz C.R.H., Saint Girons I., et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J. Immunol. 2005, 175:6022-6031.
51. Novem V., Shui G., Wang D., Bendt A.K., Sim S.H., Liu Y., Thong T.W., et al. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin. Vaccine Immunol. 2009, 16:1420-1428.
52. Ohto U., Fukase K., Miyake K., Satow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science(80-.) 2007, 316:1632-1634.
53. Ohto U., Fukase K., Miyake K., Shimizu T. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:7421-7426.
54. Panter G., Jerala R. The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation. J. Biol. Chem. 2011, 286:23334-23344.
55. Park B.S., Song D.H., Kim H.M., Choi B.-S., Lee H., Lee J.-O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458:1191-1195.
56. Que-Gewirth N.L.S., Ribeiro A.A., Kalb S.R., Cotter R.J., Bulach D.M., Adler B., Girons I.S., et al. A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J. Biol. Chem. 2004, 279:25420-25429.
57. Qureshi N., Honovich J.P., Hara H., Cotter R.J., Takayama K. Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J. Biol. Chem. 1988, 263:5502-5504.
58. Qureshi N., Takayama K., Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect. Immun. 1991, 59:441-444.
59. Qureshi N., Takayama K., Seydel U., Wang R., Cotter R.J., Agrawal P.K., Bush C.A., et al. Structural analysis of the lipid A derived from the lipopolysaccharide of Brucella abortus. J. Endotoxin Res. 1994, 1:137-148.
60. Qureshi N., Kaltashov I., Walker K., Doroshenko V., Cotter R.J., Takayama K., Sievert T.R., et al. Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatis. J. Biol. Chem. 1997, 272:10594-10600.
61. Raetz C.R. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J. Bacteriol. 1993, 175:5745-5753.
62. Raetz C.R.H., Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71:635-700.
63. Rangarajan M., Aduse-Opoku J., Paramonov N., Hashim A., Bostanci N., Fraser O.P., Tarelli E., et al. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J. Bacteriol. 2008, 190:2920-2932.
64. Rebeil R., Ernst R.K., Gowen B.B., Miller S.I., Hinnebusch B.J. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 2004, 52:1363-1373.
65. Resman N., Gradisar H., Vasl J., Keber M.M., Pristovsek P., Jerala R. Taxanes inhibit human TLR4 signaling by binding to MD-2. FEBS Lett. 2008, 582:3929-3934.
66. Resman N., Vasl J., Oblak A., Pristovsek P., Gioannini T.L., Weiss J.P., Jerala R. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J. Biol. Chem. 2009, 284:15052-15060.
67. Resman N., Oblak A., Gioannini T.L., Weiss J.P., Jerala R. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions. J. Immunol. 2014, 192:1887-1895.
68. Rund S., Lindner B., Brade H., Holst O. Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2. J. Biol. Chem. 1999, 274:16819-16824.
69. Sandström G., Sjöstedt A., Johansson T., Kuoppa K., Williams J.C. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 1992, 5:201-210.
70. Seydel U., Oikawa M., Fukase K., Kusumoto S., Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 2000, 267:3032-3039.
71. Shevchuk O., Jäger J., Steinert M. Virulence properties of the Legionella pneumophila cell envelope. Front. Microbiol. 2011, 2:74.
72. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189:1777-1782.
73. Sprong T., Ley P.v., Abdollahi-Roodsaz S., Joosten L., Meer J.v., Netea M., Deuren M.v. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production. Innate Immun. 2011, 17:517-525.
74. Steeghs L., Keestra A.M., van Mourik A., Uronen-Hansson H., van der Ley P., Callard R., Klein N., et al. Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect. Immun. 2008, 76:3801-3807.
75. Sykes B., Furr M. Equine endotoxaemia-A state-of-the-art review of therapy. Aust. Vet. J. 2005, 83:45-50.
76. Takayama K., Qureshi N., Beutler B., Kirkland T.N. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect. Immun. 1989, 57:1336-1338.
77. Tanamoto K., Azumi S. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. J. Immunol. 2000, 164:3149-3156.
78. Teghanemt A., Zhang D., Levis E.N., Weiss J.P., Gioannini T.L. Molecular basis of reduced potency of underacylated endotoxins. J. Immunol. 2005, 175:4669-4676.
79. Temperley N.D., Berlin S., Paton I.R., Griffin D.K., Burt D.W. Evolution of the chicken Toll-like receptor gene family: a story of gene gain and gene loss. BMC Genomics 2008, 9:62.
80. Vasl J., Oblak A., Gioannini T.L., Weiss J.P., Jerala R. Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2. J. Immunol. 2009, 183:5138-5145.
81. Vinogradov E., Perry M.B., Conlan J.W. Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 2002, 269:6112-6118.
82. Walsh C., Gangloff M., Monie T., Smyth T., Wei B., Mckinley T.J., Maskell D., et al. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J. Immunol. 2008, 181:1245-1254.
83. Wang X., Karbarz M.J., McGrath S.C., Cotter R.J., Raetz C.R.H. MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of Francisella novicida LpxE expressed in Escherichia coli. J. Biol. Chem. 2004, 279:49470-49478.
84. Wang X., McGrath S.C., Cotter R.J., Raetz C.R.H. Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4'-phosphatase LpxF. J. Biol. Chem. 2006, 281:9321-9330.
85. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
86. Zähringer U., Knirel Y.A., Lindner B., Helbig J.H., Sonesson A., Marre R., Rietschel E.T. The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog. Clin. Biol. Res. 1995, 392:113-139.
87. Zhang Y., Gaekwad J., Wolfert M.A., Boons G.-J. Modulation of innate immune responses with synthetic lipid A derivatives. J. Am. Chem. Soc. 2007, 129:5200-5216.
88. Zughaier S.M., Tzeng Y.-L., Zimmer S.M., Datta A., Carlson R.W., Stephens D.S. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 2004, 72:371-380.
89. Zughaier S.M., Zimmer S.M., Datta A., Carlson R.W., Stephens D.S. Differential induction of the Toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 2005, 73:2940-2950.